Annual ROE
-438.40%
+95.10%+17.83%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual return on equity is -438.40%, with the most recent change of +95.10% (+17.83%) on December 31, 2023.
- During the last 3 years, ENTO annual ROE has fallen by -1675.63% (-135.43%).
- ENTO annual ROE is now -135.43% below its all-time high of 1237.23%, reached on December 1, 2020.
Performance
ENTO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-17.85%
+9.86%+35.58%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly return on equity is -17.85%, with the most recent change of +9.86% (+35.58%) on September 1, 2024.
- Over the past year, ENTO quarterly ROE has increased by +585.23% (+97.04%).
- ENTO quarterly ROE is now -100.95% below its all-time high of 1884.69%, reached on June 1, 2017.
Performance
ENTO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ENTO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.8% | +97.0% |
| 3 y3 years | -135.4% | -105.4% |
| 5 y5 years | -44.9% | +96.7% |
ENTO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -158.6% | +17.8% | -101.3% | +99.5% |
| 5 y | 5-year | -135.4% | +17.8% | -101.3% | +99.5% |
| alltime | all time | -135.4% | +34.4% | -101.0% | +99.5% |
Entero Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -17.85%(-35.6%) |
| Jun 2024 | - | -27.71%(-3.7%) |
| Mar 2024 | - | -28.76%(-95.2%) |
| Dec 2023 | -438.40%(-17.8%) | -603.08%(-7.5%) |
| Sep 2023 | - | -652.28%(-15.8%) |
| Jun 2023 | - | -774.46%(-335.0%) |
| Mar 2023 | - | 329.49%(+29.3%) |
| Dec 2022 | -533.50%(-171.3%) | - |
| Dec 2022 | - | 254.79%(-2.1%) |
| Sep 2022 | - | 260.25%(-56.1%) |
| Jun 2022 | - | 592.43%(-58.4%) |
| Mar 2022 | - | 1423.50%(-140.4%) |
| Dec 2021 | 748.41%(-39.5%) | -3522.66%(+60.8%) |
| Sep 2021 | - | -2190.27%(+353.5%) |
| Jun 2021 | - | -482.96%(-13.9%) |
| Mar 2021 | - | -560.89%(-41.3%) |
| Dec 2020 | 1237.23% | -956.13%(+202.2%) |
| Sep 2020 | - | -316.40%(-48.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -613.41%(+34.2%) |
| Mar 2020 | - | -457.07%(+1.5%) |
| Dec 2019 | -328.72%(+8.7%) | -450.36%(-16.2%) |
| Sep 2019 | - | -537.33%(+29.2%) |
| Jun 2019 | - | -416.02%(+45.3%) |
| Mar 2019 | - | -286.25%(-0.9%) |
| Dec 2018 | -302.50%(-54.7%) | -288.98%(-4.1%) |
| Sep 2018 | - | -301.38%(-20.9%) |
| Jun 2018 | - | -381.02%(-18.5%) |
| Mar 2018 | - | -467.49%(+11.3%) |
| Dec 2017 | -668.22%(+47.1%) | -419.85%(-10.7%) |
| Sep 2017 | - | -470.04%(-124.9%) |
| Jun 2017 | - | 1884.69%(+417.2%) |
| Mar 2017 | - | 364.37%(+48.6%) |
| Dec 2016 | -454.15%(-378.0%) | 245.17%(+95.2%) |
| Sep 2016 | - | 125.63%(-7.8%) |
| Jun 2016 | - | 136.22%(-8.4%) |
| Mar 2016 | - | 148.75%(-9.0%) |
| Dec 2015 | 163.38% | 163.38% |
FAQ
- What is Entero Therapeutics annual return on equity?
- What is the all time high annual ROE for Entero Therapeutics?
- What is Entero Therapeutics annual ROE year-on-year change?
- What is Entero Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Entero Therapeutics?
- What is Entero Therapeutics quarterly ROE year-on-year change?
What is Entero Therapeutics annual return on equity?
The current annual ROE of ENTO is -438.40%
What is the all time high annual ROE for Entero Therapeutics?
Entero Therapeutics all-time high annual return on equity is 1237.23%
What is Entero Therapeutics annual ROE year-on-year change?
Over the past year, ENTO annual return on equity has changed by +95.10% (+17.83%)
What is Entero Therapeutics quarterly return on equity?
The current quarterly ROE of ENTO is -17.85%
What is the all time high quarterly ROE for Entero Therapeutics?
Entero Therapeutics all-time high quarterly return on equity is 1884.69%
What is Entero Therapeutics quarterly ROE year-on-year change?
Over the past year, ENTO quarterly return on equity has changed by +585.23% (+97.04%)